TY - JOUR
T1 - Stromal Cell-Derived Factor-1a Autocrine/Paracrine Signaling Contributes to Spatiotemporal Gradients in the Brain
AU - Hickey, Kassondra N.
AU - Grassi, Shannon M.
AU - Caplan, Michael R.
AU - Stabenfeldt, Sarah E.
N1 - Funding Information:
Kassondra N. Hickey declares that she has no conflict of interest. Shannon M. Grassi declares that she has no conflict of interest. Michael R. Caplan declares that he has no conflict of interest. Sarah E. Stabenfeldt declares that she has no conflict of interest. Sarah E. Stabenfeldt has received research grants NSF CBET 1454282 and NIH 1DP2HD084067.
Funding Information:
This work was supported by the NSF CBET 1454282 (SES) and NIH 1DP2HD084067 (SES). We thank Dr. Rachael Sirianni, Dr. Barbara Smith, Dr. Richard Miller, and Crystal Willingham for technical and materials support. We would like to acknowledge Brandon Neldner from the KE cores facilities at Arizona State University for assistance with technical setup and experimental design for the flow cytometry analysis. We also thank Scott Bingham from the Arizona State University DNA lab for assistance with RNA analysis.
Publisher Copyright:
© 2020, Biomedical Engineering Society.
PY - 2021/2
Y1 - 2021/2
N2 - Introduction: Stromal cell derived factor-1a (SDF-1a) and its receptor CXCR4 modulate stem cell recruitment to neural injury sites. SDF-1a gradients originating from injury sites contribute to chemotactic cellular recruitment. To capitalize on this injury-induced cell recruitment, further investigation of SDF-1a/CXCR4 signaling dynamics are warranted. Here, we studied how exogenous SDF-1a delivery strategies impact spatiotemporal SDF-1a levels and the role autocrine/paracrine signaling plays. Methods: We first assessed total SDF-1a and CXCR4 levels over the course of 7 days following intracortical injection of either bolus SDF-1a or SDF-1a loaded nanoparticles in CXCR4-EGFP mice. We then investigated cellular contributors to SDF-1a autocrine/paracrine signaling via time course in vitro measurements of SDF-1a and CXCR4 gene expression following exogenous SDF-1a application. Lastly, we created mathematical models that could recapitulate our in vivo observations. Results: In vivo, we found sustained total SDF-1a levels beyond 3 days post injection, indicating endogenous SDF-1a production. We confirmed in vitro that microglia, astrocytes, and brain endothelial cells significantly change SDF-1a and CXCR4 expression after exposure. We found that diffusion-only based mathematical models were unable to capture in vivo SDF-1a spatial distribution. Adding autocrine/paracrine mechanisms to the model allowed for SDF-1a temporal trends to be modeled accurately, indicating it plays an essential role in SDF-1a sustainment. Conclusions: We conclude that autocrine/paracrine dynamics play a role in endogenous SDF-1a levels in the brain following exogenous delivery. Implementation of these dynamics are necessary to improving SDF-1a delivery strategies. Further, mathematical models introduced here may be utilized in predicting future outcomes based upon new biomaterial designs.
AB - Introduction: Stromal cell derived factor-1a (SDF-1a) and its receptor CXCR4 modulate stem cell recruitment to neural injury sites. SDF-1a gradients originating from injury sites contribute to chemotactic cellular recruitment. To capitalize on this injury-induced cell recruitment, further investigation of SDF-1a/CXCR4 signaling dynamics are warranted. Here, we studied how exogenous SDF-1a delivery strategies impact spatiotemporal SDF-1a levels and the role autocrine/paracrine signaling plays. Methods: We first assessed total SDF-1a and CXCR4 levels over the course of 7 days following intracortical injection of either bolus SDF-1a or SDF-1a loaded nanoparticles in CXCR4-EGFP mice. We then investigated cellular contributors to SDF-1a autocrine/paracrine signaling via time course in vitro measurements of SDF-1a and CXCR4 gene expression following exogenous SDF-1a application. Lastly, we created mathematical models that could recapitulate our in vivo observations. Results: In vivo, we found sustained total SDF-1a levels beyond 3 days post injection, indicating endogenous SDF-1a production. We confirmed in vitro that microglia, astrocytes, and brain endothelial cells significantly change SDF-1a and CXCR4 expression after exposure. We found that diffusion-only based mathematical models were unable to capture in vivo SDF-1a spatial distribution. Adding autocrine/paracrine mechanisms to the model allowed for SDF-1a temporal trends to be modeled accurately, indicating it plays an essential role in SDF-1a sustainment. Conclusions: We conclude that autocrine/paracrine dynamics play a role in endogenous SDF-1a levels in the brain following exogenous delivery. Implementation of these dynamics are necessary to improving SDF-1a delivery strategies. Further, mathematical models introduced here may be utilized in predicting future outcomes based upon new biomaterial designs.
KW - CXCL12
KW - CXCR4
KW - Chemokines
KW - Modeling
UR - http://www.scopus.com/inward/record.url?scp=85089098396&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089098396&partnerID=8YFLogxK
U2 - 10.1007/s12195-020-00643-y
DO - 10.1007/s12195-020-00643-y
M3 - Article
AN - SCOPUS:85089098396
SN - 1865-5025
VL - 14
SP - 75
EP - 87
JO - Cellular and Molecular Bioengineering
JF - Cellular and Molecular Bioengineering
IS - 1
ER -